59 related articles for article (PubMed ID: 33277108)
21. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Park SJ
Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Fat Quantification With Novel Ultrasound Based Techniques: A Diagnostic Performance Study Using Magnetic Resonance Imaging Proton Density Fat Fraction as Reference Standard.
Şendur HN; Özdemir Kalkan D; Cerit MN; Kalkan G; Şendur AB; Özhan Oktar S
Can Assoc Radiol J; 2023 May; 74(2):362-369. PubMed ID: 36113064
[No Abstract] [Full Text] [Related]
24. Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis.
Rónaszéki AD; Budai BK; Csongrády B; Stollmayer R; Hagymási K; Werling K; Fodor T; Folhoffer A; Kalina I; Győri G; Maurovich-Horvat P; Kaposi PN
Medicine (Baltimore); 2022 Aug; 101(33):e29708. PubMed ID: 35984128
[TBL] [Abstract][Full Text] [Related]
25. Quantitative ultrasound (QUS) in the evaluation of liver steatosis: data reliability in different respiratory phases and body positions.
Rocca A; Komici K; Brunese MC; Pacella G; Avella P; Di Benedetto C; Caiazzo C; Zappia M; Brunese L; Vallone G
Radiol Med; 2024 Apr; 129(4):549-557. PubMed ID: 38512608
[TBL] [Abstract][Full Text] [Related]
26. Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease.
Jeon SK; Lee JM
Insights Imaging; 2024 Feb; 15(1):46. PubMed ID: 38353856
[TBL] [Abstract][Full Text] [Related]
27. CT-based methods for assessment of metabolic dysfunction associated with fatty liver disease.
Hu N; Yan G; Tang M; Wu Y; Song F; Xia X; Chan LW; Lei P
Eur Radiol Exp; 2023 Nov; 7(1):72. PubMed ID: 37985560
[TBL] [Abstract][Full Text] [Related]
28. Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review.
Jang W; Song JS
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296703
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications.
Zeng KY; Bao WY; Wang YH; Liao M; Yang J; Huang JY; Lu Q
World J Gastroenterol; 2023 May; 29(17):2534-2550. PubMed ID: 37213404
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
Hwang SM; Cho KY
Eur Radiol; 2023 Nov; 33(11):8353-8365. PubMed ID: 37195431
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area.
Hari A
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428882
[TBL] [Abstract][Full Text] [Related]
32. Nonalcoholic fatty liver disease and diabetes.
Bellini MI; Urciuoli I; Del Gaudio G; Polti G; Iannetti G; Gangitano E; Lori E; Lubrano C; Cantisani V; Sorrenti S; D'Andrea V
World J Diabetes; 2022 Sep; 13(9):668-682. PubMed ID: 36188142
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter.
Kim PH; Cho YA; Yoon HM; Bak B; Lee JS; Jung AY; Oh SH; Kim KM
Ultrasonography; 2022 Oct; 41(4):761-769. PubMed ID: 35765803
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques.
Park J; Lee JM; Lee G; Jeon SK; Joo I
Korean J Radiol; 2022 Jan; 23(1):13-29. PubMed ID: 34983091
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease.
Jeon SK; Lee JM; Joo I; Yoon JH
Ultrasonography; 2022 Apr; 41(2):355-364. PubMed ID: 34933319
[TBL] [Abstract][Full Text] [Related]
36. Basic concept and clinical applications of quantitative ultrasound (QUS) technologies.
Yamaguchi T
J Med Ultrason (2001); 2021 Oct; 48(4):391-402. PubMed ID: 34669072
[TBL] [Abstract][Full Text] [Related]
37. Quantitative ultrasound imaging of soft biological tissues: a primer for radiologists and medical physicists.
Cloutier G; Destrempes F; Yu F; Tang A
Insights Imaging; 2021 Sep; 12(1):127. PubMed ID: 34499249
[TBL] [Abstract][Full Text] [Related]
38. Clusters of Ultrasound Scattering Parameters for the Classification of Steatotic and Normal Livers.
Baek J; Poul SS; Basavarajappa L; Reddy S; Tai H; Hoyt K; Parker KJ
Ultrasound Med Biol; 2021 Oct; 47(10):3014-3027. PubMed ID: 34315619
[TBL] [Abstract][Full Text] [Related]
39. Clinical Feasibility of Quantitative Ultrasound Imaging for Suspected Hepatic Steatosis: Intra- and Inter-examiner Reliability and Correlation with Controlled Attenuation Parameter.
Jeon SK; Lee JM; Joo I
Ultrasound Med Biol; 2021 Mar; 47(3):438-445. PubMed ID: 33277108
[TBL] [Abstract][Full Text] [Related]
40. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
